Cross Country Healthcare released FY2025 Q1 earnings on May 7 (EST), actual revenue USD 293.41 M (forecast USD 314.82 M), actual EPS USD -0.02 (forecast USD 0.0663)

Brief Summary

Cross Country Healthcare’s Q1 2025 financial report showed a revenue of $293 million and an EPS of -$0.02, both missing market expectations of $315 million revenue and $0.0663 EPS.

Impact of The News

The financial briefing indicates that Cross Country Healthcare has underperformed against market expectations for Q1 2025, with a significant shortfall in both revenue and earnings per share (EPS). The actual revenue of $293 million was below the expected $315 million, and the EPS reported at -$0.02 missed the anticipated $0.0663. This performance positions the company unfavorably compared to some of its peers who have shown growth and surpassed market expectations, such as ARM, which reported a 34% year-over-year increase in Q4 revenue DoNews, and AMD, which exceeded market expectations with a 35.90% revenue growth . Such a shortfall could imply potential operational challenges or market conditions affecting the company’s business model or market demand. This underperformance may lead to a reevaluation of business strategies and could necessitate changes to improve financial outcomes in the subsequent quarters. Investors might anticipate cautious guidance or strategic shifts from the company as it seeks to address these performance gaps.